
Ekorab D 30mg/20mg Capsule SR
Marketer
Ekasar Lifescience
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Ekorab D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD) is effectively managed using the combined medication, Ekorab D 30mg/20mg sustained-release capsules. This treatment alleviates common GERD symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Ekorab D 30mg/20mg SR capsules should strictly follow your physician's instructions, tailored to your individual response and condition. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. Common, generally transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or mentally demanding tasks until their impact is assessed. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cool milk and avoiding caffeine, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, inform your doctor of any existing kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Ekorab D 30mg/20mg Capsule SR
No information provided. Please provide the text you wish to be rephrased.
Uses of Ekorab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Ekorab D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire capsule without chewing, crushing, or breaking it. Ekorab D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
Common Side effects of Ekorab D 30mg/20mg Capsule SR:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Ekorab D 30mg/20mg Capsule SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Consume Ekorab D 30mg/20mg SR Capsules on an empty stomach.
How Ekorab D 30mg/20mg Capsule SR works:
Ekorab D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, acting synergistically to manage gastrointestinal discomfort. Domperidone, a prokinetic agent, enhances gastric and intestinal motility, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, thereby alleviating acid reflux and indigestion symptoms.
SAFETY ADVICE
AlcoholCAUTION
Use of Ekorab D 30mg/20mg Capsule SR with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Ekorab D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Ekorab D 30mg/20mg capsule is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Ekorab D 30mg/20mg sustained-release capsules may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Ekorab D 30mg/20mg sustained-release capsules. Dosage modification of Ekorab D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Ekorab D 30mg/20mg SR capsules cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Ekorab D 30mg/20mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Ekorab D 30mg/20mg Capsule SR :
Should you forget to take a dose of Ekorab D 30mg/20mg sustained-release capsule, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ekorab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
